Donecopride (fumarate hydrate)

Donecopride is a dual-acting small molecule functioning as a 5-HT4 receptor partial agonist and a selective AChE inhibitor. It promotes sAPP-α release in vitro and demonstrates in vivo efficacy in Alzheimer's disease mouse models by reducing amyloid-β levels and improving cognitive performance in behavioral tests like NOR and Y-maze.